CA2773291A1 - Induced pluripotent stem cells and methods for obtaining them - Google Patents
Induced pluripotent stem cells and methods for obtaining them Download PDFInfo
- Publication number
- CA2773291A1 CA2773291A1 CA2773291A CA2773291A CA2773291A1 CA 2773291 A1 CA2773291 A1 CA 2773291A1 CA 2773291 A CA2773291 A CA 2773291A CA 2773291 A CA2773291 A CA 2773291A CA 2773291 A1 CA2773291 A1 CA 2773291A1
- Authority
- CA
- Canada
- Prior art keywords
- cells
- cell
- gene product
- reprogramming
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 66
- 210000004263 induced pluripotent stem cell Anatomy 0.000 title claims description 374
- 210000004027 cell Anatomy 0.000 claims abstract description 332
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 247
- 230000008672 reprogramming Effects 0.000 claims abstract description 225
- 229930002330 retinoic acid Natural products 0.000 claims abstract description 98
- 229960001727 tretinoin Drugs 0.000 claims abstract description 97
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims abstract description 96
- 210000001082 somatic cell Anatomy 0.000 claims abstract description 93
- 102000003702 retinoic acid receptors Human genes 0.000 claims abstract description 62
- 108090000064 retinoic acid receptors Proteins 0.000 claims abstract description 62
- 239000000556 agonist Substances 0.000 claims abstract description 51
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 38
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 38
- 239000005557 antagonist Substances 0.000 claims abstract description 35
- 101100405132 Mus musculus Nr5a2 gene Proteins 0.000 claims abstract description 26
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 9
- 241000282414 Homo sapiens Species 0.000 claims description 227
- 230000014509 gene expression Effects 0.000 claims description 167
- 101100411708 Danio rerio rarga gene Proteins 0.000 claims description 125
- 230000004069 differentiation Effects 0.000 claims description 30
- 210000001519 tissue Anatomy 0.000 claims description 26
- 206010043276 Teratoma Diseases 0.000 claims description 25
- 101710150336 Protein Rex Proteins 0.000 claims description 19
- 210000000056 organ Anatomy 0.000 claims description 18
- 241000699670 Mus sp. Species 0.000 claims description 17
- 238000003780 insertion Methods 0.000 claims description 17
- 230000037431 insertion Effects 0.000 claims description 17
- 239000003814 drug Substances 0.000 claims description 15
- 238000004458 analytical method Methods 0.000 claims description 14
- 239000002157 polynucleotide Substances 0.000 claims description 14
- 102100033912 Retinoic acid receptor gamma Human genes 0.000 claims description 13
- 101000687905 Homo sapiens Transcription factor SOX-2 Proteins 0.000 claims description 12
- 102100024270 Transcription factor SOX-2 Human genes 0.000 claims description 12
- 108091057508 Myc family Proteins 0.000 claims description 11
- 230000012010 growth Effects 0.000 claims description 11
- 210000000349 chromosome Anatomy 0.000 claims description 8
- 201000010099 disease Diseases 0.000 claims description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
- 108091029865 Exogenous DNA Proteins 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 6
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims description 5
- 230000017858 demethylation Effects 0.000 claims description 5
- 238000010520 demethylation reaction Methods 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 230000003595 spectral effect Effects 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 230000035755 proliferation Effects 0.000 claims description 4
- 210000004899 c-terminal region Anatomy 0.000 claims description 2
- 101150028074 2 gene Proteins 0.000 claims 1
- 101001132658 Homo sapiens Retinoic acid receptor gamma Proteins 0.000 claims 1
- 101150095164 rex1 gene Proteins 0.000 claims 1
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 137
- 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 134
- 241000699666 Mus <mouse, genus> Species 0.000 description 131
- 239000000047 product Substances 0.000 description 81
- 102000004169 proteins and genes Human genes 0.000 description 52
- 235000018102 proteins Nutrition 0.000 description 49
- 238000001890 transfection Methods 0.000 description 46
- 230000011664 signaling Effects 0.000 description 42
- 241000699660 Mus musculus Species 0.000 description 37
- 239000013598 vector Substances 0.000 description 35
- 101150066717 Rara gene Proteins 0.000 description 34
- 102100029856 Steroidogenic factor 1 Human genes 0.000 description 34
- 238000003757 reverse transcription PCR Methods 0.000 description 29
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 28
- 230000000694 effects Effects 0.000 description 25
- 230000004913 activation Effects 0.000 description 23
- 210000002950 fibroblast Anatomy 0.000 description 23
- 238000004519 manufacturing process Methods 0.000 description 23
- 108010038912 Retinoid X Receptors Proteins 0.000 description 22
- 238000010367 cloning Methods 0.000 description 21
- 230000001965 increasing effect Effects 0.000 description 20
- 239000013612 plasmid Substances 0.000 description 20
- 102100022669 Nuclear receptor subfamily 5 group A member 2 Human genes 0.000 description 19
- 230000024245 cell differentiation Effects 0.000 description 18
- 238000000338 in vitro Methods 0.000 description 17
- 102000039446 nucleic acids Human genes 0.000 description 17
- 108020004707 nucleic acids Proteins 0.000 description 17
- 150000007523 nucleic acids Chemical class 0.000 description 17
- 230000002018 overexpression Effects 0.000 description 17
- 108020004414 DNA Proteins 0.000 description 16
- 230000005283 ground state Effects 0.000 description 16
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 15
- -1 Nanog Proteins 0.000 description 15
- 238000000684 flow cytometry Methods 0.000 description 15
- 238000012744 immunostaining Methods 0.000 description 15
- 229950010131 puromycin Drugs 0.000 description 14
- 239000002299 complementary DNA Substances 0.000 description 13
- 238000004520 electroporation Methods 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 13
- 210000001654 germ layer Anatomy 0.000 description 13
- 238000004113 cell culture Methods 0.000 description 12
- 229960003722 doxycycline Drugs 0.000 description 12
- 108091008760 retinoic acid receptors γ Proteins 0.000 description 12
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 11
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 11
- 101001109685 Homo sapiens Nuclear receptor subfamily 5 group A member 2 Proteins 0.000 description 10
- 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 10
- 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- 238000012512 characterization method Methods 0.000 description 10
- 230000002068 genetic effect Effects 0.000 description 10
- 239000003112 inhibitor Substances 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 210000001778 pluripotent stem cell Anatomy 0.000 description 10
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- 241000894007 species Species 0.000 description 10
- 230000017105 transposition Effects 0.000 description 10
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 9
- 101710105538 Nuclear receptor subfamily 5 group A member 2 Proteins 0.000 description 9
- 238000011529 RT qPCR Methods 0.000 description 9
- 238000010240 RT-PCR analysis Methods 0.000 description 9
- 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 description 9
- 102000040945 Transcription factor Human genes 0.000 description 9
- 108091023040 Transcription factor Proteins 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 210000004602 germ cell Anatomy 0.000 description 9
- 230000001976 improved effect Effects 0.000 description 9
- 230000006698 induction Effects 0.000 description 9
- 230000010354 integration Effects 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 210000002966 serum Anatomy 0.000 description 9
- 230000007067 DNA methylation Effects 0.000 description 8
- 102000008579 Transposases Human genes 0.000 description 8
- 108010020764 Transposases Proteins 0.000 description 8
- 210000002257 embryonic structure Anatomy 0.000 description 8
- 239000012909 foetal bovine serum Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 101000979596 Homo sapiens NF-kappa-B-repressing factor Proteins 0.000 description 7
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 7
- 102100023379 NF-kappa-B-repressing factor Human genes 0.000 description 7
- 108091008747 NR2F3 Proteins 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 210000000130 stem cell Anatomy 0.000 description 7
- 238000013518 transcription Methods 0.000 description 7
- 230000035897 transcription Effects 0.000 description 7
- 108700028369 Alleles Proteins 0.000 description 6
- 102100028228 COUP transcription factor 1 Human genes 0.000 description 6
- 101100239628 Danio rerio myca gene Proteins 0.000 description 6
- 201000009051 Embryonal Carcinoma Diseases 0.000 description 6
- 229940122245 Janus kinase inhibitor Drugs 0.000 description 6
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 6
- 108091027981 Response element Proteins 0.000 description 6
- 239000004098 Tetracycline Substances 0.000 description 6
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 6
- 102000004142 Trypsin Human genes 0.000 description 6
- 108090000631 Trypsin Proteins 0.000 description 6
- 210000002459 blastocyst Anatomy 0.000 description 6
- 230000002500 effect on skin Effects 0.000 description 6
- 210000003953 foreskin Anatomy 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- 229960002180 tetracycline Drugs 0.000 description 6
- 229930101283 tetracycline Natural products 0.000 description 6
- 235000019364 tetracycline Nutrition 0.000 description 6
- 150000003522 tetracyclines Chemical class 0.000 description 6
- 239000012588 trypsin Substances 0.000 description 6
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 5
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 5
- 108010065376 COUP Transcription Factor I Proteins 0.000 description 5
- 101001139134 Homo sapiens Krueppel-like factor 4 Proteins 0.000 description 5
- 102100020677 Krueppel-like factor 4 Human genes 0.000 description 5
- 108060001084 Luciferase Proteins 0.000 description 5
- 239000005089 Luciferase Substances 0.000 description 5
- 101150072008 NR5A2 gene Proteins 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 102000027507 nuclear receptors type II Human genes 0.000 description 5
- 108091008686 nuclear receptors type II Proteins 0.000 description 5
- 230000037361 pathway Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 102100028226 COUP transcription factor 2 Human genes 0.000 description 4
- 108010077544 Chromatin Proteins 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 101000652324 Homo sapiens Transcription factor SOX-17 Proteins 0.000 description 4
- 102100022670 Nuclear receptor subfamily 6 group A member 1 Human genes 0.000 description 4
- 101710093927 Nuclear receptor subfamily 6 group A member 1 Proteins 0.000 description 4
- 101150023417 PPARG gene Proteins 0.000 description 4
- 102100030243 Transcription factor SOX-17 Human genes 0.000 description 4
- 210000001766 X chromosome Anatomy 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 210000003483 chromatin Anatomy 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 4
- 238000010353 genetic engineering Methods 0.000 description 4
- 210000005260 human cell Anatomy 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 238000007069 methylation reaction Methods 0.000 description 4
- 210000002569 neuron Anatomy 0.000 description 4
- 238000003753 real-time PCR Methods 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 230000002123 temporal effect Effects 0.000 description 4
- 108700026220 vif Genes Proteins 0.000 description 4
- 108020005345 3' Untranslated Regions Proteins 0.000 description 3
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 3
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 3
- 108010020650 COUP Transcription Factor II Proteins 0.000 description 3
- AQGNHMOJWBZFQQ-UHFFFAOYSA-N CT 99021 Chemical compound CC1=CNC(C=2C(=NC(NCCNC=3N=CC(=CC=3)C#N)=NC=2)C=2C(=CC(Cl)=CC=2)Cl)=N1 AQGNHMOJWBZFQQ-UHFFFAOYSA-N 0.000 description 3
- 101100202237 Danio rerio rxrab gene Proteins 0.000 description 3
- 101100309320 Danio rerio rxrga gene Proteins 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 101150099612 Esrrb gene Proteins 0.000 description 3
- 101150005894 GCLC gene Proteins 0.000 description 3
- 101000762379 Homo sapiens Bone morphogenetic protein 4 Proteins 0.000 description 3
- 101001128090 Homo sapiens Homeobox protein NANOG Proteins 0.000 description 3
- 101001094700 Homo sapiens POU domain, class 5, transcription factor 1 Proteins 0.000 description 3
- 101000652332 Homo sapiens Transcription factor SOX-1 Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 102000055601 Nanog Homeobox Human genes 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 102100037506 Paired box protein Pax-6 Human genes 0.000 description 3
- 101150099493 STAT3 gene Proteins 0.000 description 3
- 102100030248 Transcription factor SOX-1 Human genes 0.000 description 3
- 102000013814 Wnt Human genes 0.000 description 3
- 108050003627 Wnt Proteins 0.000 description 3
- 210000002593 Y chromosome Anatomy 0.000 description 3
- 239000000370 acceptor Substances 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000013020 embryo development Effects 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 238000003205 genotyping method Methods 0.000 description 3
- 230000000762 glandular Effects 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000003468 luciferase reporter gene assay Methods 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 3
- 229960005322 streptomycin Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- FRGKKTITADJNOE-UHFFFAOYSA-N sulfanyloxyethane Chemical compound CCOS FRGKKTITADJNOE-UHFFFAOYSA-N 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000013603 viral vector Substances 0.000 description 3
- WZUVPPKBWHMQCE-XJKSGUPXSA-N (+)-haematoxylin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-XJKSGUPXSA-N 0.000 description 2
- LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 description 2
- IQVNEKKDSLOHHK-FNCQTZNRSA-N (E,E)-hydramethylnon Chemical compound N1CC(C)(C)CNC1=NN=C(/C=C/C=1C=CC(=CC=1)C(F)(F)F)\C=C\C1=CC=C(C(F)(F)F)C=C1 IQVNEKKDSLOHHK-FNCQTZNRSA-N 0.000 description 2
- 102100021565 28S rRNA (cytosine-C(5))-methyltransferase Human genes 0.000 description 2
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
- 102100038008 60S ribosomal protein L22-like 1 Human genes 0.000 description 2
- 102000006822 Agouti Signaling Protein Human genes 0.000 description 2
- 108010072151 Agouti Signaling Protein Proteins 0.000 description 2
- 102100033368 Ankyrin repeat domain-containing protein 39 Human genes 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 108091005471 CRHR1 Proteins 0.000 description 2
- 102100029761 Cadherin-5 Human genes 0.000 description 2
- 102100039370 Carbohydrate deacetylase Human genes 0.000 description 2
- 208000031404 Chromosome Aberrations Diseases 0.000 description 2
- 102100030444 Coiled-coil domain-containing protein 125 Human genes 0.000 description 2
- 102100038812 Coronin-7 Human genes 0.000 description 2
- 102100038018 Corticotropin-releasing factor receptor 1 Human genes 0.000 description 2
- 241000484025 Cuniculus Species 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 101100447432 Danio rerio gapdh-2 gene Proteins 0.000 description 2
- 102100037127 Developmental pluripotency-associated protein 3 Human genes 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 241000283074 Equus asinus Species 0.000 description 2
- 108091008794 FGF receptors Proteins 0.000 description 2
- OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 2
- 102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 description 2
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 2
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 108091092584 GDNA Proteins 0.000 description 2
- 102000001267 GSK3 Human genes 0.000 description 2
- 108060006662 GSK3 Proteins 0.000 description 2
- 101150112014 Gapdh gene Proteins 0.000 description 2
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Natural products C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 102100022846 Histone acetyltransferase KAT2B Human genes 0.000 description 2
- 101710083341 Histone acetyltransferase KAT2B Proteins 0.000 description 2
- 108010033040 Histones Proteins 0.000 description 2
- 101001108583 Homo sapiens 28S rRNA (cytosine-C(5))-methyltransferase Proteins 0.000 description 2
- 101000661567 Homo sapiens 60S ribosomal protein L22-like 1 Proteins 0.000 description 2
- 101000732378 Homo sapiens Ankyrin repeat domain-containing protein 39 Proteins 0.000 description 2
- 101000794587 Homo sapiens Cadherin-5 Proteins 0.000 description 2
- 101000961486 Homo sapiens Carbohydrate deacetylase Proteins 0.000 description 2
- 101000772526 Homo sapiens Coiled-coil domain-containing protein 125 Proteins 0.000 description 2
- 101000881866 Homo sapiens Developmental pluripotency-associated protein 3 Proteins 0.000 description 2
- 101000602930 Homo sapiens Nuclear receptor coactivator 2 Proteins 0.000 description 2
- 101000888114 Homo sapiens Polypeptide N-acetylgalactosaminyltransferase 16 Proteins 0.000 description 2
- 101000797874 Homo sapiens Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 Proteins 0.000 description 2
- 101000694402 Homo sapiens RNA transcription, translation and transport factor protein Proteins 0.000 description 2
- 101001061807 Homo sapiens Rab-like protein 6 Proteins 0.000 description 2
- 101000819088 Homo sapiens Transcription factor GATA-6 Proteins 0.000 description 2
- 101000610557 Homo sapiens U4/U6 small nuclear ribonucleoprotein Prp31 Proteins 0.000 description 2
- 101000809046 Homo sapiens Ubiquitin conjugation factor E4 B Proteins 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- 102100030353 Membrane-associated phosphatidylinositol transfer protein 1 Human genes 0.000 description 2
- 101100225547 Mus musculus Ehmt2 gene Proteins 0.000 description 2
- 101100011486 Mus musculus Elf4 gene Proteins 0.000 description 2
- 241000699667 Mus spretus Species 0.000 description 2
- 102100037226 Nuclear receptor coactivator 2 Human genes 0.000 description 2
- 102000016978 Orphan receptors Human genes 0.000 description 2
- 108070000031 Orphan receptors Proteins 0.000 description 2
- 108010032788 PAX6 Transcription Factor Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- SHGAZHPCJJPHSC-UHFFFAOYSA-N Panrexin Chemical compound OC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-UHFFFAOYSA-N 0.000 description 2
- 102100039228 Polypeptide N-acetylgalactosaminyltransferase 16 Human genes 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 102100032337 Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 Human genes 0.000 description 2
- 102100027122 RNA transcription, translation and transport factor protein Human genes 0.000 description 2
- 238000011530 RNeasy Mini Kit Methods 0.000 description 2
- 101150050070 RXRA gene Proteins 0.000 description 2
- 102100029618 Rab-like protein 6 Human genes 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 108010048349 Steroidogenic Factor 1 Proteins 0.000 description 2
- 101150047500 TERT gene Proteins 0.000 description 2
- 102100021382 Transcription factor GATA-6 Human genes 0.000 description 2
- 102100033026 Transmembrane protein 102 Human genes 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 102100040118 U4/U6 small nuclear ribonucleoprotein Prp31 Human genes 0.000 description 2
- 102100038487 Ubiquitin conjugation factor E4 B Human genes 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 102100023550 Zinc finger protein 42 homolog Human genes 0.000 description 2
- 101150063416 add gene Proteins 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 230000003828 downregulation Effects 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 238000010195 expression analysis Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 238000012239 gene modification Methods 0.000 description 2
- 230000005017 genetic modification Effects 0.000 description 2
- 235000013617 genetically modified food Nutrition 0.000 description 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000003716 mesoderm Anatomy 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007479 molecular analysis Methods 0.000 description 2
- NFVJNJQRWPQVOA-UHFFFAOYSA-N n-[2-chloro-5-(trifluoromethyl)phenyl]-2-[3-(4-ethyl-5-ethylsulfanyl-1,2,4-triazol-3-yl)piperidin-1-yl]acetamide Chemical compound CCN1C(SCC)=NN=C1C1CN(CC(=O)NC=2C(=CC=C(C=2)C(F)(F)F)Cl)CCC1 NFVJNJQRWPQVOA-UHFFFAOYSA-N 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000004853 protein function Effects 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- 238000011536 re-plating Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000001177 retroviral effect Effects 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 102220032988 rs281865408 Human genes 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 108020003113 steroid hormone receptors Proteins 0.000 description 2
- 102000005969 steroid hormone receptors Human genes 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000009044 synergistic interaction Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 108091006106 transcriptional activators Proteins 0.000 description 2
- GHKCSRZBNZQHKW-UWTATZPHSA-N (1R)-1-sulfanylethanol Chemical compound C[C@H](O)S GHKCSRZBNZQHKW-UWTATZPHSA-N 0.000 description 1
- 101150084750 1 gene Proteins 0.000 description 1
- CDAISMWEOUEBRE-LKPKBOIGSA-N 1D-chiro-inositol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O CDAISMWEOUEBRE-LKPKBOIGSA-N 0.000 description 1
- NMUSYJAQQFHJEW-UHFFFAOYSA-N 5-Azacytidine Natural products O=C1N=C(N)N=CN1C1C(O)C(O)C(CO)O1 NMUSYJAQQFHJEW-UHFFFAOYSA-N 0.000 description 1
- XAUDJQYHKZQPEU-KVQBGUIXSA-N 5-aza-2'-deoxycytidine Chemical compound O=C1N=C(N)N=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 XAUDJQYHKZQPEU-KVQBGUIXSA-N 0.000 description 1
- NMUSYJAQQFHJEW-KVTDHHQDSA-N 5-azacytidine Chemical compound O=C1N=C(N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NMUSYJAQQFHJEW-KVTDHHQDSA-N 0.000 description 1
- 101150039504 6 gene Proteins 0.000 description 1
- 101150087690 ACTB gene Proteins 0.000 description 1
- 101150058497 ANPEP gene Proteins 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010059616 Activins Proteins 0.000 description 1
- 102100022749 Aminopeptidase N Human genes 0.000 description 1
- 101150079087 Arfgef2 gene Proteins 0.000 description 1
- 102100022999 Ataxin-7-like protein 1 Human genes 0.000 description 1
- 101000765604 Bacillus subtilis (strain 168) FlaA locus 22.9 kDa protein Proteins 0.000 description 1
- 108060000903 Beta-catenin Proteins 0.000 description 1
- 102000015735 Beta-catenin Human genes 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102100028573 Brefeldin A-inhibited guanine nucleotide-exchange protein 2 Human genes 0.000 description 1
- 101710188751 COUP transcription factor 1 Proteins 0.000 description 1
- 101710188750 COUP transcription factor 2 Proteins 0.000 description 1
- 101150094485 COX6A2 gene Proteins 0.000 description 1
- 101000964402 Caldicellulosiruptor saccharolyticus Uncharacterized protein in xynC 3'region Proteins 0.000 description 1
- 108091005462 Cation channels Proteins 0.000 description 1
- 102100034755 Centrosomal protein of 85 kDa Human genes 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 101150087297 Chst3 gene Proteins 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 108010060434 Co-Repressor Proteins Proteins 0.000 description 1
- 102000008169 Co-Repressor Proteins Human genes 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108010028776 Complement C7 Proteins 0.000 description 1
- 102100024336 Complement component C7 Human genes 0.000 description 1
- 108050006322 Coronin 7 Proteins 0.000 description 1
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 1
- 108090000365 Cytochrome-c oxidases Proteins 0.000 description 1
- 230000035131 DNA demethylation Effects 0.000 description 1
- 101100202242 Danio rerio rxrba gene Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 1
- 102100037124 Developmental pluripotency-associated 5 protein Human genes 0.000 description 1
- 102100029857 Dipeptidase 3 Human genes 0.000 description 1
- 101100015729 Drosophila melanogaster drk gene Proteins 0.000 description 1
- 102100027418 E3 ubiquitin-protein ligase RNF213 Human genes 0.000 description 1
- 102000020897 Formins Human genes 0.000 description 1
- 108091022623 Formins Proteins 0.000 description 1
- 102100021200 G-protein coupled receptor 176 Human genes 0.000 description 1
- 101710101475 G-protein coupled receptor 176 Proteins 0.000 description 1
- 101150020110 GPR176 gene Proteins 0.000 description 1
- 102100033299 Glia-derived nexin Human genes 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 101150071692 Gpr156 gene Proteins 0.000 description 1
- 102100028539 Guanylate-binding protein 5 Human genes 0.000 description 1
- 101710110795 Guanylate-binding protein 5 Proteins 0.000 description 1
- 101150091137 HRH1 gene Proteins 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 108010020382 Hepatocyte Nuclear Factor 1-alpha Proteins 0.000 description 1
- 102100022057 Hepatocyte nuclear factor 1-alpha Human genes 0.000 description 1
- 102100032509 Histamine H1 receptor Human genes 0.000 description 1
- 101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 description 1
- 101000974896 Homo sapiens Ataxin-7-like protein 1 Proteins 0.000 description 1
- 101000695920 Homo sapiens Brefeldin A-inhibited guanine nucleotide-exchange protein 2 Proteins 0.000 description 1
- 101000945822 Homo sapiens Centrosomal protein of 85 kDa Proteins 0.000 description 1
- 101000957299 Homo sapiens Coronin-7 Proteins 0.000 description 1
- 101000881848 Homo sapiens Developmental pluripotency-associated 5 protein Proteins 0.000 description 1
- 101000864130 Homo sapiens Dipeptidase 3 Proteins 0.000 description 1
- 101000650316 Homo sapiens E3 ubiquitin-protein ligase RNF213 Proteins 0.000 description 1
- 101000997803 Homo sapiens Glia-derived nexin Proteins 0.000 description 1
- 101001072655 Homo sapiens Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial Proteins 0.000 description 1
- 101001016841 Homo sapiens Histamine H1 receptor Proteins 0.000 description 1
- 101001001429 Homo sapiens Inositol monophosphatase 1 Proteins 0.000 description 1
- 101000998969 Homo sapiens Inositol-3-phosphate synthase 1 Proteins 0.000 description 1
- 101000971801 Homo sapiens KH domain-containing protein 3 Proteins 0.000 description 1
- 101000942967 Homo sapiens Leukemia inhibitory factor Proteins 0.000 description 1
- 101000583145 Homo sapiens Membrane-associated phosphatidylinositol transfer protein 1 Proteins 0.000 description 1
- 101001133056 Homo sapiens Mucin-1 Proteins 0.000 description 1
- 101001030211 Homo sapiens Myc proto-oncogene protein Proteins 0.000 description 1
- 101000996034 Homo sapiens Nodal homolog Proteins 0.000 description 1
- 101001134126 Homo sapiens Nuclear pore membrane glycoprotein 210-like Proteins 0.000 description 1
- 101000601647 Homo sapiens Paired box protein Pax-6 Proteins 0.000 description 1
- 101001068628 Homo sapiens Protein PRRC2C Proteins 0.000 description 1
- 101000657326 Homo sapiens Protein TANC2 Proteins 0.000 description 1
- 101001069691 Homo sapiens Protogenin Proteins 0.000 description 1
- 101000889749 Homo sapiens Putative ATP-dependent RNA helicase TDRD12 Proteins 0.000 description 1
- 101000608194 Homo sapiens Pyrin domain-containing protein 1 Proteins 0.000 description 1
- 101000814438 Homo sapiens Retinoschisin Proteins 0.000 description 1
- 101000628693 Homo sapiens Serine/threonine-protein kinase 25 Proteins 0.000 description 1
- 101000702653 Homo sapiens Sorting nexin-1 Proteins 0.000 description 1
- 101000666730 Homo sapiens T-complex protein 1 subunit alpha Proteins 0.000 description 1
- 101000837443 Homo sapiens T-complex protein 1 subunit beta Proteins 0.000 description 1
- 101000800590 Homo sapiens Transducin beta-like protein 2 Proteins 0.000 description 1
- 101000633089 Homo sapiens Transient receptor potential cation channel subfamily V member 2 Proteins 0.000 description 1
- 101000655133 Homo sapiens Transmembrane protein 102 Proteins 0.000 description 1
- 101000808654 Homo sapiens Ubiquitin conjugation factor E4 A Proteins 0.000 description 1
- 101000777245 Homo sapiens Undifferentiated embryonic cell transcription factor 1 Proteins 0.000 description 1
- 101000976622 Homo sapiens Zinc finger protein 42 homolog Proteins 0.000 description 1
- 101100540311 Human papillomavirus type 16 E6 gene Proteins 0.000 description 1
- 101000767631 Human papillomavirus type 16 Protein E7 Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102100026818 Inhibin beta E chain Human genes 0.000 description 1
- 102100035679 Inositol monophosphatase 1 Human genes 0.000 description 1
- 101710090028 Inositol-3-phosphate synthase 1 Proteins 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- 230000004163 JAK-STAT signaling pathway Effects 0.000 description 1
- 102100021450 KH domain-containing protein 3 Human genes 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 108700021430 Kruppel-Like Factor 4 Proteins 0.000 description 1
- 101710128836 Large T antigen Proteins 0.000 description 1
- 101000977779 Lymantria dispar multicapsid nuclear polyhedrosis virus Uncharacterized 33.9 kDa protein in PE 3'region Proteins 0.000 description 1
- 102000019149 MAP kinase activity proteins Human genes 0.000 description 1
- 108040008097 MAP kinase activity proteins Proteins 0.000 description 1
- 102100025169 Max-binding protein MNT Human genes 0.000 description 1
- 101710104271 Membrane-associated phosphatidylinositol transfer protein 1 Proteins 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 101710113645 Mitochondrial ribosome-associated GTPase 2 Proteins 0.000 description 1
- 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 description 1
- 102100034256 Mucin-1 Human genes 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 101100215374 Mus musculus Actb gene Proteins 0.000 description 1
- 101000804949 Mus musculus Developmental pluripotency-associated protein 2 Proteins 0.000 description 1
- 101000881849 Mus musculus Developmental pluripotency-associated protein 4 Proteins 0.000 description 1
- 101100499399 Mus musculus H2-DMa gene Proteins 0.000 description 1
- 101100116982 Mus musculus H2-DMb1 gene Proteins 0.000 description 1
- 101000942966 Mus musculus Leukemia inhibitory factor Proteins 0.000 description 1
- 101100346932 Mus musculus Muc1 gene Proteins 0.000 description 1
- 101100189471 Mus musculus Pbx1 gene Proteins 0.000 description 1
- 101100454357 Mus musculus Slc43a1 gene Proteins 0.000 description 1
- 101000976618 Mus musculus Zinc finger protein 42 Proteins 0.000 description 1
- 108010021466 Mutant Proteins Proteins 0.000 description 1
- 102000008300 Mutant Proteins Human genes 0.000 description 1
- 101710150912 Myc protein Proteins 0.000 description 1
- 102100030856 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 108091008637 NR5A Proteins 0.000 description 1
- 108091061960 Naked DNA Proteins 0.000 description 1
- 101000827630 Narcissus mosaic virus Uncharacterized 10 kDa protein Proteins 0.000 description 1
- 102100034457 Nodal homolog Human genes 0.000 description 1
- 101150013593 Nr5a1 gene Proteins 0.000 description 1
- 108020005497 Nuclear hormone receptor Proteins 0.000 description 1
- 102100034218 Nuclear pore membrane glycoprotein 210-like Human genes 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 101150036111 PFN4 gene Proteins 0.000 description 1
- 101150095051 PRTG gene Proteins 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 101710105361 Phosphoglucomutase 1 Proteins 0.000 description 1
- 102100030999 Phosphoglucomutase-1 Human genes 0.000 description 1
- 108010076311 Pre-B-Cell Leukemia Transcription Factor 1 Proteins 0.000 description 1
- 102100040171 Pre-B-cell leukemia transcription factor 1 Human genes 0.000 description 1
- 102100033952 Protein PRRC2C Human genes 0.000 description 1
- 102100034784 Protein TANC2 Human genes 0.000 description 1
- 102100033834 Protogenin Human genes 0.000 description 1
- 102100040195 Putative ATP-dependent RNA helicase TDRD12 Human genes 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- 102000005583 Pyrin Human genes 0.000 description 1
- 108010059278 Pyrin Proteins 0.000 description 1
- 102100039892 Pyrin domain-containing protein 1 Human genes 0.000 description 1
- 101150097436 RXRB gene Proteins 0.000 description 1
- 108010038036 Receptor Activator of Nuclear Factor-kappa B Proteins 0.000 description 1
- 102100039507 Retinoschisin Human genes 0.000 description 1
- 101150085412 Rxrg gene Proteins 0.000 description 1
- 108091006207 SLC-Transporter Proteins 0.000 description 1
- 102000037054 SLC-Transporter Human genes 0.000 description 1
- 108091006172 SLC21 Proteins 0.000 description 1
- 101150042431 SOX gene Proteins 0.000 description 1
- 102100026737 Serine/threonine-protein kinase 25 Human genes 0.000 description 1
- 101150026500 Slc4a4 gene Proteins 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 102100030992 Sorting nexin-1 Human genes 0.000 description 1
- 102100024803 Sorting nexin-29 Human genes 0.000 description 1
- 101710182433 Sorting nexin-29 Proteins 0.000 description 1
- 101150037203 Sox2 gene Proteins 0.000 description 1
- 241000862969 Stella Species 0.000 description 1
- 102000004896 Sulfotransferases Human genes 0.000 description 1
- 108090001033 Sulfotransferases Proteins 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 102100038410 T-complex protein 1 subunit alpha Human genes 0.000 description 1
- 102100028679 T-complex protein 1 subunit beta Human genes 0.000 description 1
- 101150047304 TMOD1 gene Proteins 0.000 description 1
- 101150098315 TRPV4 gene Proteins 0.000 description 1
- 101150075440 Tanc2 gene Proteins 0.000 description 1
- 101150111019 Tbx3 gene Proteins 0.000 description 1
- 208000035199 Tetraploidy Diseases 0.000 description 1
- 102100033248 Transducin beta-like protein 2 Human genes 0.000 description 1
- 102100029621 Transient receptor potential cation channel subfamily V member 2 Human genes 0.000 description 1
- 101710171006 Transmembrane protein 102 Proteins 0.000 description 1
- 102000009149 Tropomodulin-1 Human genes 0.000 description 1
- 108050000021 Tropomodulin-1 Proteins 0.000 description 1
- 101150077905 Trpv2 gene Proteins 0.000 description 1
- 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
- 102100028787 Tumor necrosis factor receptor superfamily member 11A Human genes 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 102100031278 Undifferentiated embryonic cell transcription factor 1 Human genes 0.000 description 1
- 101000929049 Xenopus tropicalis Derriere protein Proteins 0.000 description 1
- 101710160552 Zinc finger protein 42 Proteins 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000488 activin Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108010054176 apotransferrin Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960002756 azacitidine Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000010370 cell cloning Methods 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 238000012761 co-transfection Methods 0.000 description 1
- OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010205 computational analysis Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000007911 de novo DNA methylation Effects 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 229940124447 delivery agent Drugs 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 101150088049 dna2 gene Proteins 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 210000003981 ectoderm Anatomy 0.000 description 1
- 210000002242 embryoid body Anatomy 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 210000001900 endoderm Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000008995 epigenetic change Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 229960002963 ganciclovir Drugs 0.000 description 1
- 238000003633 gene expression assay Methods 0.000 description 1
- 238000010363 gene targeting Methods 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 210000002175 goblet cell Anatomy 0.000 description 1
- 101150098203 grb2 gene Proteins 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 230000006197 histone deacetylation Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 102000046645 human LIF Human genes 0.000 description 1
- 210000001182 human Y chromosome Anatomy 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004777 loss-of-function mutation Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 108010082117 matrigel Proteins 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000000276 neural tube Anatomy 0.000 description 1
- 102000006255 nuclear receptors Human genes 0.000 description 1
- 108020004017 nuclear receptors Proteins 0.000 description 1
- 238000011580 nude mouse model Methods 0.000 description 1
- 102000004164 orphan nuclear receptors Human genes 0.000 description 1
- 108090000629 orphan nuclear receptors Proteins 0.000 description 1
- 210000003134 paneth cell Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000003094 perturbing effect Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 230000004983 pleiotropic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- JJICLMJFIKGAAU-UHFFFAOYSA-M sodium;2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)purin-6-olate Chemical compound [Na+].NC1=NC([O-])=C2N=CN(COC(CO)CO)C2=N1 JJICLMJFIKGAAU-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000011476 stem cell transplantation Methods 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 108091006107 transcriptional repressors Proteins 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000012250 transgenic expression Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000024540 transposon integration Effects 0.000 description 1
- 102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000008189 vertebrate development Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/235—Leukemia inhibitory factor [LIF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/602—Sox-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/603—Oct-3/4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/604—Klf-4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/606—Transcription factors c-Myc
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases [EC 2.]
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Developmental Biology & Embryology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24028209P | 2009-09-07 | 2009-09-07 | |
| US61/240,282 | 2009-09-07 | ||
| GB0915523.5 | 2009-09-07 | ||
| GBGB0915523.5A GB0915523D0 (en) | 2009-09-07 | 2009-09-07 | Cells and methods for obtaining them |
| US27620309P | 2009-09-08 | 2009-09-08 | |
| US61/276,203 | 2009-09-08 | ||
| PCT/GB2010/051493 WO2011027180A1 (en) | 2009-09-07 | 2010-09-07 | Cells and methods for obtaining them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2773291A1 true CA2773291A1 (en) | 2011-03-10 |
Family
ID=41203246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2773291A Abandoned CA2773291A1 (en) | 2009-09-07 | 2010-09-07 | Induced pluripotent stem cells and methods for obtaining them |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9512407B2 (enExample) |
| EP (1) | EP2475774A1 (enExample) |
| JP (1) | JP5944315B2 (enExample) |
| CN (1) | CN102822345B (enExample) |
| CA (1) | CA2773291A1 (enExample) |
| GB (1) | GB0915523D0 (enExample) |
| SG (2) | SG178613A1 (enExample) |
| WO (1) | WO2011027180A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011040887A1 (en) * | 2009-09-30 | 2011-04-07 | Agency For Science, Technology And Research | A nuclear receptor and mutant thereof and the use of the same in the reprogramming of cells |
| CA2814713A1 (en) * | 2010-10-14 | 2012-04-19 | University Of Central Florida Research Foundation, Inc. | Cardiac induced pluripotent stem cells and methods of use in repair and regeneration of myocardium |
| GB2496375A (en) | 2011-10-28 | 2013-05-15 | Kymab Ltd | A non-human assay vertebrate comprising human antibody loci and human epitope knock-in, and uses thereof |
| GB201122047D0 (en) | 2011-12-21 | 2012-02-01 | Kymab Ltd | Transgenic animals |
| CA2924735C (en) * | 2013-09-20 | 2023-02-28 | Lonza Ltd | Methods for nuclear reprogramming of cells |
| US10023879B2 (en) * | 2014-06-04 | 2018-07-17 | Fate Therapeutics, Inc. | Minimal volume reprogramming of mononuclear cells |
| WO2017091943A1 (en) | 2015-11-30 | 2017-06-08 | Hong Guan Ltd. | Improved methods for reprograming non-pluripotent cells into pluripotent stem cells |
| CN109750000A (zh) * | 2017-11-06 | 2019-05-14 | 内蒙古赛科星家畜种业与繁育生物技术研究院有限公司 | 利用XistTale抑制性转录因子R6制备新型动物细胞系R6-MEFs方法及用途 |
| CN109913494A (zh) * | 2019-02-12 | 2019-06-21 | 北京呈诺医学科技有限公司 | 一种新的ips细胞的诱导方法 |
| CN110218741B (zh) * | 2019-05-31 | 2020-12-25 | 华中农业大学 | 采用串联sgRNA同步激活多个猪内源性干细胞因子转录活性的方法 |
| CN110592014A (zh) * | 2019-08-14 | 2019-12-20 | 广东美赛尔细胞生物科技有限公司 | 一种在nk细胞治疗中免辐照体外体内持续去除饲养细胞的方法 |
| CN114703227B (zh) * | 2022-01-27 | 2023-11-10 | 中国科学院生态环境研究中心 | 基于MCF-7细胞系构建的RARα效应物体外筛选方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2020198A1 (en) | 1989-06-30 | 1990-12-31 | Pierre Chambon | Human and mouse retinoic acid receptors and genes encoding for them |
| US5663303A (en) | 1991-11-04 | 1997-09-02 | Institut National De La Sante Et De La Recherche Medicale | Antibodies specific for retinoic acid receptor-γ |
| AU6589801A (en) | 2000-04-28 | 2001-11-12 | F. Hoffmann-La Roche Ag | P-(sulfonyl)aryl and heteroaryls |
| US20070224615A1 (en) * | 2003-07-09 | 2007-09-27 | Invitrogen Corporation | Methods for assaying protein-protein interactions |
| US7476673B2 (en) | 2003-12-30 | 2009-01-13 | Allergan, Inc. | Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors |
| WO2005080973A1 (en) | 2004-02-13 | 2005-09-01 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human nuclear receptor nr5a1 (nr5a1) |
| US20080227864A1 (en) | 2004-02-24 | 2008-09-18 | Bryan James Goodwin | Lhr1 Activators as Medicaments |
| CA2617611A1 (en) | 2005-08-01 | 2007-02-08 | Nupotential, Llc | Production of reprogrammed cells with restored potential |
| US8048999B2 (en) | 2005-12-13 | 2011-11-01 | Kyoto University | Nuclear reprogramming factor |
| WO2008064136A2 (en) | 2006-11-17 | 2008-05-29 | Acadia Pharmaceuticals Inc. | Compounds with activity at retinoic acid receptors |
| ATE554775T1 (de) | 2007-11-16 | 2012-05-15 | Baylor College Medicine | Phospholipid-zusammensetzungen und ihre verwendungen |
| US9683232B2 (en) | 2007-12-10 | 2017-06-20 | Kyoto University | Efficient method for nuclear reprogramming |
| AU2008286249B2 (en) | 2007-12-10 | 2013-10-10 | Kyoto University | Efficient method for nuclear reprogramming |
| CN101250502A (zh) * | 2008-04-01 | 2008-08-27 | 中国科学院上海生命科学研究院 | 一种诱导的多潜能干细胞的制备方法 |
| WO2011040887A1 (en) | 2009-09-30 | 2011-04-07 | Agency For Science, Technology And Research | A nuclear receptor and mutant thereof and the use of the same in the reprogramming of cells |
-
2009
- 2009-09-07 GB GBGB0915523.5A patent/GB0915523D0/en not_active Ceased
-
2010
- 2010-09-07 US US13/394,481 patent/US9512407B2/en not_active Expired - Fee Related
- 2010-09-07 CA CA2773291A patent/CA2773291A1/en not_active Abandoned
- 2010-09-07 WO PCT/GB2010/051493 patent/WO2011027180A1/en not_active Ceased
- 2010-09-07 SG SG2012015343A patent/SG178613A1/en unknown
- 2010-09-07 EP EP10754364A patent/EP2475774A1/en not_active Withdrawn
- 2010-09-07 CN CN201080050341.XA patent/CN102822345B/zh not_active Expired - Fee Related
- 2010-09-07 SG SG10201405455UA patent/SG10201405455UA/en unknown
- 2010-09-07 JP JP2012527396A patent/JP5944315B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102822345B (zh) | 2016-06-08 |
| JP2013503622A (ja) | 2013-02-04 |
| WO2011027180A1 (en) | 2011-03-10 |
| SG10201405455UA (en) | 2014-10-30 |
| US9512407B2 (en) | 2016-12-06 |
| JP5944315B2 (ja) | 2016-07-05 |
| CN102822345A (zh) | 2012-12-12 |
| US20120315703A1 (en) | 2012-12-13 |
| GB0915523D0 (en) | 2009-10-07 |
| EP2475774A1 (en) | 2012-07-18 |
| SG178613A1 (en) | 2012-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9512407B2 (en) | Cells and methods for obtaining them | |
| US20230282445A1 (en) | Method of nuclear reprogramming | |
| US12012615B2 (en) | Method of making induced pluripotent stem cells using p53 inhibitors | |
| CA2770412C (en) | Method of efficiently establishing induced pluripotent stem cells | |
| CA2789749C (en) | Method of efficiently establishing induced pluripotent stem cells | |
| JP5562231B2 (ja) | 効率的な人工多能性幹細胞の樹立方法 | |
| CN102190731B (zh) | 用人工转录因子诱导产生多能干细胞 | |
| US20110250692A1 (en) | Method for producing induced pluripotent stem cells | |
| AU2012256014B2 (en) | Use of Zscan4 and Zscan4-dependent genes for direct reprogramming of somatic cells | |
| WO2007069666A1 (ja) | 核初期化因子 | |
| AU2016293647B2 (en) | Method for producing high-quality iPS cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20150904 |
|
| FZDE | Dead |
Effective date: 20190522 |